NDC 60505-6237 – Deferoxamine mesylate
Deferoxamine Mesylate 2 g/1 · Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous
Product NDC60505-6237
Product details
- Brand name
- Deferoxamine mesylate
- Generic name
- Deferoxamine mesylate
- Labeler
- Apotex Corp.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA207384
- Marketed since
- November 5, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Iron Chelator
Active ingredients
- Deferoxamine Mesylate 2 g/1
Uses, dosage, side effects and warnings for Deferoxamine mesylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 60505-6237-6 | 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6) | Nov 5, 2021 |
Other Deferoxamine mesylate products
- 60505-6236 Deferoxamine Mesylate 500 mg/1 · Injection, Powder, Lyophilized, For Solution · Apotex Corp.
- 68083-172 Deferoxamine Mesylate 500 mg/1 · Injection, Powder, Lyophilized, For Solution · Gland Pharma Limited
- 68083-173 Deferoxamine Mesylate 2 g/1 · Injection, Powder, Lyophilized, For Solution · Gland Pharma Limited
- 0409-2337 Deferoxamine Mesylate 2 g/1 · Injection, Powder, Lyophilized, For Solution · Hospira, Inc.